An internal patent review committee is the decision-making core of a mature IP governance framework. It determines which inventions are converted into enforceable legal rights, which are retained as trade secrets, and which are abandoned or defensively published. Without a formal review structure, patent filing decisions are typically reactive, inventor-driven, and disconnected from long-term commercial and valuation objectives.
In advanced in-house environments, the Patent Review Committee (PRC) functions as a fiduciary control body. It sits between R&D, legal, finance, and external counsel. Its decisions directly affect capital efficiency, enforceability, freedom to operate risk, and enterprise valuation during investment, M&A, and IPO events.
Strategic Architecture of the Patent Review Committee (PRC)
Defining the Composition: Technical, Legal, and Commercial Stakes
A PRC must be cross-functional by design. Patentability is not a purely legal inquiry, and commercial relevance is not a purely technical one.
Core members typically include:
· Technical leads or senior architects who can assess novelty, feasibility, and alternatives.
· In-house legal or IP counsel responsible for statutory compliance under the Indian Patents Act, 1970, and coordination with global filing strategy.
· Product or business stakeholders who understand roadmap alignment, customer impact, and monetization pathways.
In early-stage companies, the CTO and CEO often jointly perform PRC functions. As the portfolio grows, a dedicated Head of IP or IP Manager becomes essential to mediate between R&D ambition and legal discipline.
The committee should remain small. Three to five voting members is optimal. Larger committees tend to dilute accountability and slow priority decisions.
Establishing the Governance Charter and Fiduciary Duties
The PRC must operate under a written governance charter approved by senior management. This document is not procedural formality. It defines authority, accountability, and auditability.
The charter should specify:
· Meeting cadence and quorum
· Voting thresholds and escalation paths
· Documentation standards for decisions
· Confidentiality and conflict-of-interest rules
From a fiduciary standpoint, the charter and meeting minutes establish that patent expenditures were reasoned business decisions rather than arbitrary legal costs. During M&A or IPO diligence, this documentation is frequently reviewed to assess whether the IP portfolio was built deliberately or opportunistically.
Aligning PRC Decisions with Corporate Valuation Goals
The goal of the PRC is not filing volume. It is valuation leverage.
A high-quality PRC aligns every filing with one or more of the following outcomes:
· Defensive moat creation around core products
· Blocking positions that restrict competitor design-arounds
· Licensing optionality in non-core but valuable technology
· Strategic leverage for cross-licensing or settlement
Patents that do not support at least one of these outcomes rarely justify their lifecycle costs.
Operationalizing the Review Workflow: From IDF to Filing Decision
The PRC workflow typically begins with an Invention Disclosure Form submitted by engineering or R&D teams. The committee’s role is to convert disclosures into structured legal outcomes through consistent evaluation.
Quantitative Scoring Models for Inventive Step and Novelty
Scoring models reduce bias and bring comparability across disclosures.
Common scoring dimensions include:
· Novelty score relative to known prior art
· Inventive step strength based on technical contribution
· Detectability of infringement in a competitor product
· Business impact tied to revenue or strategic importance
· Geographic relevance for global markets
Scores do not replace legal analysis. They identify which disclosures merit immediate filing and which require refinement or deferral.
Evaluating Section 3(k) and 3(d) Eligibility Risks at the Source
The PRC must anticipate examiner behavior before drafting begins.
· Section 3(k) scrutiny requires identification of technical effect, system interaction, or hardware coupling for software and AI inventions.
· Section 3(d) analysis requires early evidence of enhanced efficacy for pharmaceutical and chemical derivatives.
Based on current IPO examination practice, inventions that do not address these exclusions at the committee stage face prolonged prosecution, repeated objections, and reduced claim scope.
Framework: The 3-Tier Priority Matrix for Global Filings
|
Tier |
Strategy |
Jurisdictions |
|
Tier 1 (Core) |
Immediate filing and PCT route |
India, US, EU, China, Japan |
|
Tier 2 (Defensive) |
Limited filing with market monitoring |
India, US |
|
Tier 3 (Publish) |
Defensive publication |
Public disclosure only |
This framework allows disciplined allocation of budget without delaying priority dates.
Decision-Making Logic: Patenting vs. Trade Secret Protection
One of the PRC’s most critical responsibilities is deciding whether an invention should be patented or retained as a trade secret.
Assessing Reverse-Engineering Difficulty and Market Longevity
The guiding question is visibility.
· Patent when the invention is externally observable or easily reverse-engineered.
· Trade secret when the value lies in internal processes, backend systems, or non-observable parameters.
This decision must be explicitly recorded. Inconsistent or undocumented choices weaken enforcement and due diligence defensibility.
Disclosure Risks in Defense and Dual-Use Technology Verticals
In defense, aerospace, and dual-use sectors, patenting can trigger secrecy directions or export control complications.
Where disclosure risk outweighs exclusivity benefits, the PRC may recommend trade secret protection supported by enhanced internal controls rather than patent filing.
Cost-Benefit Analysis of Maintenance and Annuity Cycles
Patents impose long-term financial obligations. The PRC should conduct periodic pruning exercises.
If a patented technology no longer supports active products or licensing strategy, abandonment may be commercially rational. Savings can be redeployed to protect emerging innovations.
Governance and Compliance: Mitigating Legal Risks
Managing Conflicts of Interest and Inventor Neutrality
PRC credibility depends on neutrality.
Any member listed as an inventor on a disclosure under review should recuse themselves from final voting. This avoids prestige-driven filings and strengthens governance integrity.
Documenting the Rational Basis for Decisions to Withstand Future Audits
In the event of shareholder derivative suits or audits during an IPO, the company must prove that IP spend was rational.
Decision records should capture:
· Prior art reviewed
· Eligibility risks identified
· Commercial justification
· Jurisdictional choices
These records are critical during shareholder reviews, IPO diligence, and post-acquisition audits.
Section 39 Compliance: Oversight of Foreign Filing Licenses (FFL)
The PRC must ensure that inventions originating in India are not filed abroad without compliance.
Failure to obtain a foreign filing license where required can result in abandonment of Indian rights and potential criminal exposure. Centralized PRC oversight significantly reduces this risk.
Performance Metrics and PRC Accountability
A patent review committee must be accountable for portfolio quality.
Tracking Conversion Rates: From Disclosure to Granted Patent
Useful metrics include:
· Disclosure-to-filing conversion rate
· Filing-to-grant success rate
· Average office action depth
· Time from disclosure to priority filing
Extremes in either direction often indicate governance failure rather than success.
Auditing External Counsel Performance via PRC Feedback Loops
The PRC should periodically assess whether external counsel faithfully translate committee intent into claim strategy.
Repeated misalignment is a governance signal. Vendor continuation should depend on PRC feedback, not legacy relationships.
Checklist: Conducting an Annual PRC Governance Audit
· Charter compliance and meeting cadence
· Completeness and security of decision logs
· Proof of right and inventorship verification
· Annuity and renewal pruning review
· Conflict recusal documentation
Frequently asked questions (FAQs)
How many members should a PRC have?
Three to five members is optimal for most organizations.
How often should the PRC meet?
Monthly for active R&D teams. Quarterly for slower
cycles.
What
happens if an invention is rejected?
The inventor
should receive structured feedback to encourage refinement rather than
disengagement.
Can
PRC decisions be appealed?
Yes. The charter
should define a limited escalation path, typically to the CTO or Head of Legal.
How
are consultant inventions handled?
With heightened
scrutiny on contractual assignment and ownership clarity.
Should
litigation risk be considered at filing stage?
Yes. Crowded or
aggressive enforcement fields require more cautious filing strategies.
How is
confidentiality preserved?
Through internal
NDAs, access controls, and privileged marking of minutes where applicable.
Is the
PRC responsible for Freedom to Operate searches?
The PRC
initiates FTO decisions. Execution is typically delegated.
Can
the PRC authorize defensive publications?
Yes. Defensive
publication is a valid strategic outcome.
What
is a patent harvest session?
A structured
session where the PRC and engineers identify latent inventions within active
projects.